In a clinical trial carried out on 96 lung cancer patients, resveratrol suppressed tumor growth by downregulating Forkhead box C2 (FOXC2) and upregulating miR-520h-mediated PP2A/C expression, thereby causing apoptosis in lung cancer cells [405]. The gene discussed is FOXC2; the disease is lung cancer.